Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. De Smet (Ghent, Belgium), P. Mestdagh (Ghent, Belgium), F. Cobos (Ghent, Belgium), E. Blomme (Ghent, Belgium), F. Verhamme (Ghent, Belgium), S. Provoost (Ghent, Belgium), T. Maes (Ghent, Belgium), G. Joos (Ghent, Belgium), G. Brusselle (Ghent, Belgium), K. Bracke (Ghent, Belgium). The role of microRNA-155 in cigarette smoke-induced inflammation.. 2170

Member's Comments

No comment yet.

Related content which might interest you: Involvement of NCOA4-mediated ferritinophagy in cigarette smoke-induced ferroptosis in COPD pathogenesis Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Role of activin-A in cigarette smoke-induced inflammation and COPD Source: Eur Respir J 2014; 43: 1028-1041 Year: 2014 Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation Source: Eur Respir J 2015; 45: 1669-1680 Year: 2015 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 A role of mTOR in cigarette smoke-induced corticosteroid insensitivity Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012 Cigarette smoke-induced emphysema occurs in the absence of TLR4-signalling in a murine model of COPD Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 ATRvD1 reverts cigarette smoke-induced emphysema by pro-resolutive and antioxidant effects Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD Source: ERS Lung Science Conference 2020 Year: 2020 Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice Source: Eur Respir J 2015; 46: 1451-1460 Year: 2015 Propolis reverts cigarette smoke-induced emphysema through macrophage alternative activation Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 LSC - 2017 - IL-17-mediated inflammation promotes cigarette smoke-induced genomic instability Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The AMPK-TSC1/2-mTOR signaling pathway regulates cigarette smoking-induced inflammation and apoptosis in airway epithelial cells Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products Year: 2015 Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis Source: Annual Congress 2008 - Airway cell biology Year: 2008 LATE-BREAKING ABSTRACT: BRP-39 contribute to cigarette smoke-induced inflammation and emphysema in mice and humans Source: Annual Congress 2009 - Airway cell biology Year: 2009 Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis Source: Eur Respir J 2009; 33: 405-416 Year: 2009 Role of ß2-adrenergic receptor in cigarette smoke-induced COPD in mice Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 cPLA2alpha plays a role in neutrophilic inflammatory response in mice induced by tobacco smoke exposure Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013